Accent Capital Management »

ResMed shares owned by Accent Capital Management

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Accent Capital Management from 13F filings

Historical chart of Accent Capital Management investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Accent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Accent Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $227k 1.1k 209.64
2025-12-31 $4.3k 18 240.89
2025-09-30 $4.9k 18 273.72

More positions owned by Accent Capital Management

Spdr Gold Tr Gold Shs (GLD)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
NVIDIA Corporation (NVDA)
Ishares Tr S&p 500 Grwt Etf (IVW)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)

View all positions for Accent Capital Management

Top funds holding ResMed

Vanguard Group
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Swedbank AB
Charles Schwab Investment Management
Amundi

View all funds holding ResMed